Global Molecular Point-of-Care Testing Market Growth (Status and Outlook) 2026-2032

August 2026 | 130 pages | ID: GE0356523404EN
LP Information

Abstracts

The global Molecular Point-of-Care Testing market size is predicted to grow from US$ 7918 million in 2025 to US$ 10980 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032.

Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.

The global molecular point-of-care testing (POCT) market refers to the market for diagnostic tests that can be performed at or near the point of patient care, providing rapid and accurate results for a wide range of diseases and conditions. Molecular POCT involves the use of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), to detect and identify specific genetic material or biomarkers associated with diseases or infections.

Here are some key factors influencing the growth of the global molecular POCT market:

Increasing demand for rapid and accurate diagnostic testing: The need for rapid and accurate diagnostic testing is driving the growth of the molecular POCT market. Molecular POCT offers advantages such as rapid turnaround time, portability, and the ability to provide accurate results at the point of care, eliminating the need for sample transportation to centralized laboratories. This is particularly beneficial in emergency and critical care settings, where timely diagnosis is crucial for effective patient management.

Technological advancements in molecular diagnostics: Molecular diagnostic technologies have witnessed significant advancements in recent years, enabling the development of portable, user-friendly, and easy-to-operate molecular POCT devices. These devices offer rapid and reliable results, making them suitable for use in various healthcare settings, including hospitals, clinics, ambulatory care centers, and remote or resource-limited areas. Technological advancements continue to drive the growth of the molecular POCT market.

Rising prevalence of infectious diseases: The global burden of infectious diseases, such as respiratory infections, sexually transmitted infections (STIs), and gastrointestinal infections, remains significant. Molecular POCT plays a crucial role in the rapid detection and identification of pathogens responsible for these infections. The increasing prevalence of infectious diseases, coupled with the need for early diagnosis and treatment, is boosting the demand for molecular POCT solutions.

Growing focus on personalized medicine: Personalized medicine aims to tailor medical treatments to individual patients based on their genetic makeup, lifestyle, and other factors. Molecular POCT plays a vital role in enabling personalized medicine by providing rapid and accurate genetic testing at the point of care. These tests help identify genetic variations, mutations, or biomarkers that can guide treatment decisions and improve patient outcomes. The growing focus on personalized medicine is driving the adoption of molecular POCT.

COVID-19 pandemic impact: The ongoing COVID-19 pandemic has significantly accelerated the demand for molecular POCT. Rapid and accurate testing for SARS-CoV-2, the virus responsible for COVID-19, has been crucial in controlling the spread of the disease and managing patient care effectively. Molecular POCT devices, such as rapid antigen tests and molecular NAATs, have been widely used for COVID-19 testing in various healthcare settings.

The global molecular POCT market can be segmented based on technology (PCR, NAATs, hybridization, and others), application (infectious diseases, oncology, genetics, and others), end-user (hospitals, clinics, ambulatory care centers, research institutes, and others), and geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa).

In summary, the global molecular POCT market is driven by the increasing demand for rapid and accurate diagnostic testing, technological advancements in molecular diagnostics, the rising prevalence of infectious diseases, the growing focus on personalized medicine, and the impact of the COVID-19 pandemic. Molecular POCT offers the advantage of providing rapid and accurate results at the point of care, enabling timely and appropriate patient management. The market is expected to witness significant growth as the demand for portable and user-friendly molecular diagnostic solutions continues to rise.

LPI (LP Information)' newest research report, the “Molecular Point-of-Care Testing Industry Forecast” looks at past sales and reviews total world Molecular Point-of-Care Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Molecular Point-of-Care Testing sales for 2026 through 2032. With Molecular Point-of-Care Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Point-of-Care Testing industry.

This Insight Report provides a comprehensive analysis of the global Molecular Point-of-Care Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Point-of-Care Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Point-of-Care Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Point-of-Care Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Point-of-Care Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Point-of-Care Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Polymerase Chain Reaction (PCR)
• Loop-mediated Isothermal Amplification (LAMP)
• Nucleic Acid Sequence-based Amplification (NASBA)

Segmentation by Application:

• Infectious Diseases
• Genetic Disorders
• Pregnancy Testing
• Diagnosis of Cancer
• Pharmacogenomics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche Molecular Diagnostics
• Roche Diagnostics
• Abbott Laboratories
• Danaher Corporation
• bioM?rieux, Inc.
• Hologic, Inc.
• Meridian Bioscience, Inc.
• Saw Diagnostics
• Siemens Healthineer
• Sona Nanotech
• T2 Biosystems
• Talis Biomedical
• Thermo Fisher Scientific Inc.
• Veramarx
• XCR Diagnostics
• Zhejiang Orient Gene Biotech

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
    2.1.1 Global Molecular Point-of-Care Testing Market Size (2021-2032)
    2.1.2 Molecular Point-of-Care Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
    2.1.3 World Current & Future Analysis for Molecular Point-of-Care Testing by Country/Region (2021, 2025 & 2032)
  2.2 Molecular Point-of-Care Testing Segment by Type
    2.2.1 Polymerase Chain Reaction (PCR)
    2.2.2 Loop-mediated Isothermal Amplification (LAMP)
    2.2.3 Nucleic Acid Sequence-based Amplification (NASBA)
    2.2.4 Molecular Point-of-Care Testing Market Size by Type
      2.2.4.1 Molecular Point-of-Care Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
      2.2.4.2 Global Molecular Point-of-Care Testing Market Size Market Share by Type (2021-2026)
  2.3 Molecular Point-of-Care Testing Segment by Application
    2.3.1 Infectious Diseases
    2.3.2 Genetic Disorders
    2.3.3 Pregnancy Testing
    2.3.4 Diagnosis of Cancer
    2.3.5 Pharmacogenomics
    2.3.6 Molecular Point-of-Care Testing Market Size by Application
      2.3.6.1 Molecular Point-of-Care Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
      2.3.6.2 Global Molecular Point-of-Care Testing Market Size Market Share by Application (2021-2026)

3 MOLECULAR POINT-OF-CARE TESTING MARKET SIZE BY PLAYER

  3.1 Molecular Point-of-Care Testing Market Size Market Share by Player
    3.1.1 Global Molecular Point-of-Care Testing Revenue by Player (2021-2026)
    3.1.2 Global Molecular Point-of-Care Testing Revenue Market Share by Player (2021-2026)
  3.2 Global Molecular Point-of-Care Testing Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
    3.3.1 Competition Landscape Analysis
    3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 MOLECULAR POINT-OF-CARE TESTING BY REGION

  4.1 Molecular Point-of-Care Testing Market Size by Region (2021-2026)
  4.2 Global Molecular Point-of-Care Testing Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Molecular Point-of-Care Testing Market Size Growth (2021-2026)
  4.4 APAC Molecular Point-of-Care Testing Market Size Growth (2021-2026)
  4.5 Europe Molecular Point-of-Care Testing Market Size Growth (2021-2026)
  4.6 Middle East & Africa Molecular Point-of-Care Testing Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Molecular Point-of-Care Testing Market Size by Country (2021-2026)
  5.2 Americas Molecular Point-of-Care Testing Market Size by Type (2021-2026)
  5.3 Americas Molecular Point-of-Care Testing Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Molecular Point-of-Care Testing Market Size by Region (2021-2026)
  6.2 APAC Molecular Point-of-Care Testing Market Size by Type (2021-2026)
  6.3 APAC Molecular Point-of-Care Testing Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Molecular Point-of-Care Testing Market Size by Country (2021-2026)
  7.2 Europe Molecular Point-of-Care Testing Market Size by Type (2021-2026)
  7.3 Europe Molecular Point-of-Care Testing Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Molecular Point-of-Care Testing by Region (2021-2026)
  8.2 Middle East & Africa Molecular Point-of-Care Testing Market Size by Type (2021-2026)
  8.3 Middle East & Africa Molecular Point-of-Care Testing Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL MOLECULAR POINT-OF-CARE TESTING MARKET FORECAST

  10.1 Global Molecular Point-of-Care Testing Forecast by Region (2027-2032)
    10.1.1 Global Molecular Point-of-Care Testing Forecast by Region (2027-2032)
    10.1.2 Americas Molecular Point-of-Care Testing Forecast
    10.1.3 APAC Molecular Point-of-Care Testing Forecast
    10.1.4 Europe Molecular Point-of-Care Testing Forecast
    10.1.5 Middle East & Africa Molecular Point-of-Care Testing Forecast
  10.2 Americas Molecular Point-of-Care Testing Forecast by Country (2027-2032)
    10.2.1 United States Market Molecular Point-of-Care Testing Forecast
    10.2.2 Canada Market Molecular Point-of-Care Testing Forecast
    10.2.3 Mexico Market Molecular Point-of-Care Testing Forecast
    10.2.4 Brazil Market Molecular Point-of-Care Testing Forecast
  10.3 APAC Molecular Point-of-Care Testing Forecast by Region (2027-2032)
    10.3.1 China Molecular Point-of-Care Testing Market Forecast
    10.3.2 Japan Market Molecular Point-of-Care Testing Forecast
    10.3.3 Korea Market Molecular Point-of-Care Testing Forecast
    10.3.4 Southeast Asia Market Molecular Point-of-Care Testing Forecast
    10.3.5 India Market Molecular Point-of-Care Testing Forecast
    10.3.6 Australia Market Molecular Point-of-Care Testing Forecast
  10.4 Europe Molecular Point-of-Care Testing Forecast by Country (2027-2032)
    10.4.1 Germany Market Molecular Point-of-Care Testing Forecast
    10.4.2 France Market Molecular Point-of-Care Testing Forecast
    10.4.3 UK Market Molecular Point-of-Care Testing Forecast
    10.4.4 Italy Market Molecular Point-of-Care Testing Forecast
    10.4.5 Russia Market Molecular Point-of-Care Testing Forecast
  10.5 Middle East & Africa Molecular Point-of-Care Testing Forecast by Region (2027-2032)
    10.5.1 Egypt Market Molecular Point-of-Care Testing Forecast
    10.5.2 South Africa Market Molecular Point-of-Care Testing Forecast
    10.5.3 Israel Market Molecular Point-of-Care Testing Forecast
    10.5.4 Turkey Market Molecular Point-of-Care Testing Forecast
  10.6 Global Molecular Point-of-Care Testing Forecast by Type (2027-2032)
  10.7 Global Molecular Point-of-Care Testing Forecast by Application (2027-2032)
    10.7.1 GCC Countries Market Molecular Point-of-Care Testing Forecast

11 KEY PLAYERS ANALYSIS

  11.1 Roche Molecular Diagnostics
    11.1.1 Roche Molecular Diagnostics Company Information
    11.1.2 Roche Molecular Diagnostics Molecular Point-of-Care Testing Product Offered
    11.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.1.4 Roche Molecular Diagnostics Main Business Overview
    11.1.5 Roche Molecular Diagnostics Latest Developments
  11.2 Roche Diagnostics
    11.2.1 Roche Diagnostics Company Information
    11.2.2 Roche Diagnostics Molecular Point-of-Care Testing Product Offered
    11.2.3 Roche Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.2.4 Roche Diagnostics Main Business Overview
    11.2.5 Roche Diagnostics Latest Developments
  11.3 Abbott Laboratories
    11.3.1 Abbott Laboratories Company Information
    11.3.2 Abbott Laboratories Molecular Point-of-Care Testing Product Offered
    11.3.3 Abbott Laboratories Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.3.4 Abbott Laboratories Main Business Overview
    11.3.5 Abbott Laboratories Latest Developments
  11.4 Danaher Corporation
    11.4.1 Danaher Corporation Company Information
    11.4.2 Danaher Corporation Molecular Point-of-Care Testing Product Offered
    11.4.3 Danaher Corporation Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.4.4 Danaher Corporation Main Business Overview
    11.4.5 Danaher Corporation Latest Developments
  11.5 bioM?rieux, Inc.
    11.5.1 bioM?rieux, Inc. Company Information
    11.5.2 bioM?rieux, Inc. Molecular Point-of-Care Testing Product Offered
    11.5.3 bioM?rieux, Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.5.4 bioM?rieux, Inc. Main Business Overview
    11.5.5 bioM?rieux, Inc. Latest Developments
  11.6 Hologic, Inc.
    11.6.1 Hologic, Inc. Company Information
    11.6.2 Hologic, Inc. Molecular Point-of-Care Testing Product Offered
    11.6.3 Hologic, Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.6.4 Hologic, Inc. Main Business Overview
    11.6.5 Hologic, Inc. Latest Developments
  11.7 Meridian Bioscience, Inc.
    11.7.1 Meridian Bioscience, Inc. Company Information
    11.7.2 Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product Offered
    11.7.3 Meridian Bioscience, Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.7.4 Meridian Bioscience, Inc. Main Business Overview
    11.7.5 Meridian Bioscience, Inc. Latest Developments
  11.8 Saw Diagnostics
    11.8.1 Saw Diagnostics Company Information
    11.8.2 Saw Diagnostics Molecular Point-of-Care Testing Product Offered
    11.8.3 Saw Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.8.4 Saw Diagnostics Main Business Overview
    11.8.5 Saw Diagnostics Latest Developments
  11.9 Siemens Healthineer
    11.9.1 Siemens Healthineer Company Information
    11.9.2 Siemens Healthineer Molecular Point-of-Care Testing Product Offered
    11.9.3 Siemens Healthineer Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.9.4 Siemens Healthineer Main Business Overview
    11.9.5 Siemens Healthineer Latest Developments
  11.10 Sona Nanotech
    11.10.1 Sona Nanotech Company Information
    11.10.2 Sona Nanotech Molecular Point-of-Care Testing Product Offered
    11.10.3 Sona Nanotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.10.4 Sona Nanotech Main Business Overview
    11.10.5 Sona Nanotech Latest Developments
  11.11 T2 Biosystems
    11.11.1 T2 Biosystems Company Information
    11.11.2 T2 Biosystems Molecular Point-of-Care Testing Product Offered
    11.11.3 T2 Biosystems Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.11.4 T2 Biosystems Main Business Overview
    11.11.5 T2 Biosystems Latest Developments
  11.12 Talis Biomedical
    11.12.1 Talis Biomedical Company Information
    11.12.2 Talis Biomedical Molecular Point-of-Care Testing Product Offered
    11.12.3 Talis Biomedical Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.12.4 Talis Biomedical Main Business Overview
    11.12.5 Talis Biomedical Latest Developments
  11.13 Thermo Fisher Scientific Inc.
    11.13.1 Thermo Fisher Scientific Inc. Company Information
    11.13.2 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product Offered
    11.13.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.13.4 Thermo Fisher Scientific Inc. Main Business Overview
    11.13.5 Thermo Fisher Scientific Inc. Latest Developments
  11.14 Veramarx
    11.14.1 Veramarx Company Information
    11.14.2 Veramarx Molecular Point-of-Care Testing Product Offered
    11.14.3 Veramarx Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.14.4 Veramarx Main Business Overview
    11.14.5 Veramarx Latest Developments
  11.15 XCR Diagnostics
    11.15.1 XCR Diagnostics Company Information
    11.15.2 XCR Diagnostics Molecular Point-of-Care Testing Product Offered
    11.15.3 XCR Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.15.4 XCR Diagnostics Main Business Overview
    11.15.5 XCR Diagnostics Latest Developments
  11.16 Zhejiang Orient Gene Biotech
    11.16.1 Zhejiang Orient Gene Biotech Company Information
    11.16.2 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product Offered
    11.16.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2021-2026)
    11.16.4 Zhejiang Orient Gene Biotech Main Business Overview
    11.16.5 Zhejiang Orient Gene Biotech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Molecular Point-of-Care Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Molecular Point-of-Care Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Polymerase Chain Reaction (PCR)
Table 4. Major Players of Loop-mediated Isothermal Amplification (LAMP)
Table 5. Major Players of Nucleic Acid Sequence-based Amplification (NASBA)
Table 6. Molecular Point-of-Care Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Molecular Point-of-Care Testing Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Molecular Point-of-Care Testing Market Size Market Share by Type (2021-2026)
Table 9. Molecular Point-of-Care Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Molecular Point-of-Care Testing Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Molecular Point-of-Care Testing Market Size Market Share by Application (2021-2026)
Table 12. Global Molecular Point-of-Care Testing Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Molecular Point-of-Care Testing Revenue Market Share by Player (2021-2026)
Table 14. Molecular Point-of-Care Testing Key Players Head office and Products Offered
Table 15. Molecular Point-of-Care Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Point-of-Care Testing Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Molecular Point-of-Care Testing Market Size Market Share by Region (2021-2026)
Table 20. Global Molecular Point-of-Care Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Molecular Point-of-Care Testing Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Molecular Point-of-Care Testing Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Molecular Point-of-Care Testing Market Size Market Share by Country (2021-2026)
Table 24. Americas Molecular Point-of-Care Testing Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Molecular Point-of-Care Testing Market Size Market Share by Type (2021-2026)
Table 26. Americas Molecular Point-of-Care Testing Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Molecular Point-of-Care Testing Market Size Market Share by Application (2021-2026)
Table 28. APAC Molecular Point-of-Care Testing Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Molecular Point-of-Care Testing Market Size Market Share by Region (2021-2026)
Table 30. APAC Molecular Point-of-Care Testing Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Molecular Point-of-Care Testing Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Molecular Point-of-Care Testing Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Molecular Point-of-Care Testing Market Size Market Share by Country (2021-2026)
Table 34. Europe Molecular Point-of-Care Testing Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Molecular Point-of-Care Testing Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Molecular Point-of-Care Testing Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Molecular Point-of-Care Testing Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Molecular Point-of-Care Testing Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Molecular Point-of-Care Testing
Table 40. Key Market Challenges & Risks of Molecular Point-of-Care Testing
Table 41. Key Industry Trends of Molecular Point-of-Care Testing
Table 42. Global Molecular Point-of-Care Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Molecular Point-of-Care Testing Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Molecular Point-of-Care Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Molecular Point-of-Care Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Roche Molecular Diagnostics Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 47. Roche Molecular Diagnostics Molecular Point-of-Care Testing Product Offered
Table 48. Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Roche Molecular Diagnostics Main Business
Table 50. Roche Molecular Diagnostics Latest Developments
Table 51. Roche Diagnostics Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 52. Roche Diagnostics Molecular Point-of-Care Testing Product Offered
Table 53. Roche Diagnostics Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Roche Diagnostics Main Business
Table 55. Roche Diagnostics Latest Developments
Table 56. Abbott Laboratories Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 57. Abbott Laboratories Molecular Point-of-Care Testing Product Offered
Table 58. Abbott Laboratories Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Abbott Laboratories Main Business
Table 60. Abbott Laboratories Latest Developments
Table 61. Danaher Corporation Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 62. Danaher Corporation Molecular Point-of-Care Testing Product Offered
Table 63. Danaher Corporation Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Danaher Corporation Main Business
Table 65. Danaher Corporation Latest Developments
Table 66. bioM?rieux, Inc. Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 67. bioM?rieux, Inc. Molecular Point-of-Care Testing Product Offered
Table 68. bioM?rieux, Inc. Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. bioM?rieux, Inc. Main Business
Table 70. bioM?rieux, Inc. Latest Developments
Table 71. Hologic, Inc. Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 72. Hologic, Inc. Molecular Point-of-Care Testing Product Offered
Table 73. Hologic, Inc. Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Hologic, Inc. Main Business
Table 75. Hologic, Inc. Latest Developments
Table 76. Meridian Bioscience, Inc. Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 77. Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product Offered
Table 78. Meridian Bioscience, Inc. Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Meridian Bioscience, Inc. Main Business
Table 80. Meridian Bioscience, Inc. Latest Developments
Table 81. Saw Diagnostics Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 82. Saw Diagnostics Molecular Point-of-Care Testing Product Offered
Table 83. Saw Diagnostics Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Saw Diagnostics Main Business
Table 85. Saw Diagnostics Latest Developments
Table 86. Siemens Healthineer Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 87. Siemens Healthineer Molecular Point-of-Care Testing Product Offered
Table 88. Siemens Healthineer Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Siemens Healthineer Main Business
Table 90. Siemens Healthineer Latest Developments
Table 91. Sona Nanotech Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 92. Sona Nanotech Molecular Point-of-Care Testing Product Offered
Table 93. Sona Nanotech Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Sona Nanotech Main Business
Table 95. Sona Nanotech Latest Developments
Table 96. T2 Biosystems Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 97. T2 Biosystems Molecular Point-of-Care Testing Product Offered
Table 98. T2 Biosystems Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. T2 Biosystems Main Business
Table 100. T2 Biosystems Latest Developments
Table 101. Talis Biomedical Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 102. Talis Biomedical Molecular Point-of-Care Testing Product Offered
Table 103. Talis Biomedical Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Talis Biomedical Main Business
Table 105. Talis Biomedical Latest Developments
Table 106. Thermo Fisher Scientific Inc. Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 107. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product Offered
Table 108. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Thermo Fisher Scientific Inc. Main Business
Table 110. Thermo Fisher Scientific Inc. Latest Developments
Table 111. Veramarx Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 112. Veramarx Molecular Point-of-Care Testing Product Offered
Table 113. Veramarx Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Veramarx Main Business
Table 115. Veramarx Latest Developments
Table 116. XCR Diagnostics Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 117. XCR Diagnostics Molecular Point-of-Care Testing Product Offered
Table 118. XCR Diagnostics Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. XCR Diagnostics Main Business
Table 120. XCR Diagnostics Latest Developments
Table 121. Zhejiang Orient Gene Biotech Details, Company Type, Molecular Point-of-Care Testing Area Served and Its Competitors
Table 122. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product Offered
Table 123. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Zhejiang Orient Gene Biotech Main Business
Table 125. Zhejiang Orient Gene Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Molecular Point-of-Care Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Point-of-Care Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Molecular Point-of-Care Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Molecular Point-of-Care Testing Sales Market Share by Country/Region (2025)
Figure 8. Molecular Point-of-Care Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Molecular Point-of-Care Testing Market Size Market Share by Type in 2025
Figure 10. Molecular Point-of-Care Testing in Infectious Diseases
Figure 11. Global Molecular Point-of-Care Testing Market: Infectious Diseases (2021-2026) & ($ millions)
Figure 12. Molecular Point-of-Care Testing in Genetic Disorders
Figure 13. Global Molecular Point-of-Care Testing Market: Genetic Disorders (2021-2026) & ($ millions)
Figure 14. Molecular Point-of-Care Testing in Pregnancy Testing
Figure 15. Global Molecular Point-of-Care Testing Market: Pregnancy Testing (2021-2026) & ($ millions)
Figure 16. Molecular Point-of-Care Testing in Diagnosis of Cancer
Figure 17. Global Molecular Point-of-Care Testing Market: Diagnosis of Cancer (2021-2026) & ($ millions)
Figure 18. Molecular Point-of-Care Testing in Pharmacogenomics
Figure 19. Global Molecular Point-of-Care Testing Market: Pharmacogenomics (2021-2026) & ($ millions)
Figure 20. Global Molecular Point-of-Care Testing Market Size Market Share by Application in 2025
Figure 21. Global Molecular Point-of-Care Testing Revenue Market Share by Player in 2025
Figure 22. Global Molecular Point-of-Care Testing Market Size Market Share by Region (2021-2026)
Figure 23. Americas Molecular Point-of-Care Testing Market Size 2021-2026 ($ millions)
Figure 24. APAC Molecular Point-of-Care Testing Market Size 2021-2026 ($ millions)
Figure 25. Europe Molecular Point-of-Care Testing Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Molecular Point-of-Care Testing Market Size 2021-2026 ($ millions)
Figure 27. Americas Molecular Point-of-Care Testing Value Market Share by Country in 2025
Figure 28. United States Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Molecular Point-of-Care Testing Market Size Market Share by Region in 2025
Figure 33. APAC Molecular Point-of-Care Testing Market Size Market Share by Type (2021-2026)
Figure 34. APAC Molecular Point-of-Care Testing Market Size Market Share by Application (2021-2026)
Figure 35. China Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. India Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Molecular Point-of-Care Testing Market Size Market Share by Country in 2025
Figure 42. Europe Molecular Point-of-Care Testing Market Size Market Share by Type (2021-2026)
Figure 43. Europe Molecular Point-of-Care Testing Market Size Market Share by Application (2021-2026)
Figure 44. Germany Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. France Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Molecular Point-of-Care Testing Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Molecular Point-of-Care Testing Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Molecular Point-of-Care Testing Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Molecular Point-of-Care Testing Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 58. APAC Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 59. Europe Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 61. United States Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 62. Canada Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 63. Mexico Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 64. Brazil Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 65. China Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 66. Japan Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 67. Korea Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 69. India Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 70. Australia Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 71. Germany Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 72. France Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 73. UK Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 74. Italy Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 75. Russia Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 76. Egypt Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 77. South Africa Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 78. Israel Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 79. Turkey Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)
Figure 80. Global Molecular Point-of-Care Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Molecular Point-of-Care Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Molecular Point-of-Care Testing Market Size 2027-2032 ($ millions)